Methods for treating anxiety related disorders
AssigneeHythlam, Inc.
InventorsSanjay Sabnani, Donald Wesson
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of and compositions for treating and relieving symptoms and disease associated with indications caused by a physiological drive to alleviate a sensation of anxiety. In one treatment method, methods of, and compositions for, modulating the expression of certain GABAA receptor subunits are used to treat anxiety-related disorders and depressive disorders associated with physiological tolerance to endogenous neurosteroids.
Claims5
A method of treating an obsessive compulsive disorder in a patient comprising administering to the patient a composition comprising flumazenil in a pharmaceutically acceptable carrier, wherein the flumazenil is administered in a therapeutically effective quantity.
Dependencies are inferred from the claim text.